These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2525990)

  • 1. [Role of vitamin D3 in hematology].
    Petrini M; Bilancia D; Risaliti M; Ambrogi F; Grassi B
    Clin Ter; 1989 Jan; 128(1):33-8. PubMed ID: 2525990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of myelodysplastic syndrome and acute myelogenous leukemia with vitamin D3 [1 alpha(OH)D3]].
    Irino S; Taoka T
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-2):1183-90. PubMed ID: 2837981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of 1,25-dihydroxyvitamin D3 and 13-cis-retinoic acid on in vitro hematopoiesis in the myelodysplastic syndromes.
    Nagler A; Rikilis I; Tatarsky I; Fabian I
    J Lab Clin Med; 1987 Aug; 110(2):237-44. PubMed ID: 3474327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 24-Oxo metabolites of vitamin D3 analogues: disassociation of their prominent antileukemic effects from their lack of calcium modulation.
    Shiohara M; Uskokovic M; Hisatake J; Hisatake Y; Koike K; Komiyama A; Koeffler HP
    Cancer Res; 2001 Apr; 61(8):3361-8. PubMed ID: 11309293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of macrophage differentiation of human normal and leukemic myeloid stem cells by 1,25-dihydroxyvitamin D3 and its fluorinated analogues.
    Koeffler HP; Amatruda T; Ikekawa N; Kobayashi Y; DeLuca HF
    Cancer Res; 1984 Dec; 44(12 Pt 1):5624-8. PubMed ID: 6594194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of a potent 20-epi-vitamin D3 analogue (KH 1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells.
    Elstner E; Linker-Israeli M; Umiel T; Le J; Grillier I; Said J; Shintaku IP; Krajewski S; Reed JC; Binderup L; Koeffler HP
    Cancer Res; 1996 Aug; 56(15):3570-6. PubMed ID: 8758928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5,6-trans-16-ene-vitamin D3: a new class of potent inhibitors of proliferation of prostate, breast, and myeloid leukemic cells.
    Hisatake J; Kubota T; Hisatake Y; Uskokovic M; Tomoyasu S; Koeffler HP
    Cancer Res; 1999 Aug; 59(16):4023-9. PubMed ID: 10463602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
    Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
    Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant gamma-interferon and lipopolysaccharide enhance 1,25-dihydroxyvitamin D3-induced cell differentiation in human promyelocytic leukemia (HL-60) cells.
    Murao SI; Fukumoto Y; Katayama M; Maeda H; Sugiyama T; Huberman E
    Jpn J Cancer Res; 1985 Jul; 76(7):596-602. PubMed ID: 3928556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Induction of myelogenous differentiation: a therapeutic possibility for preleukemia and acute leukemia?].
    Tobler A
    Schweiz Med Wochenschr; 1988 May; 118(18):669-75. PubMed ID: 3291104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Divergent regulation of 1,25-dihydroxyvitamin D3 on human bone marrow osteoclastogenesis and myelopoiesis.
    Qi DY; Perkins SL; Kling SJ; Russell RG
    J Cell Biochem; 1999 Mar; 72(3):387-95. PubMed ID: 10022520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition by 1alpha,25-dihydroxyvitamin D3 of activin A-induced differentiation of murine erythroleukemic F5-5 cells.
    Nagasaki T; Hino M; Inaba M; Nishizawa Y; Morii H; Otani S
    Arch Biochem Biophys; 1997 Jul; 343(2):181-7. PubMed ID: 9224728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro stimulation of articular chondrocyte differentiated function by 1,25-dihydroxycholecalciferol or 24R,25-dihydroxycholecalciferol.
    Harmand MF; Thomasset M; Rouais F; Ducassou D
    J Cell Physiol; 1984 Jun; 119(3):359-65. PubMed ID: 6725420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of vitamin D3 metabolites on normal and leukemic bone marrow cells in vitro.
    McCarthy D; Hibbin J; San Miguel JF; Freake H; Rodrigues B; Andrews C; Pinching A; Catovsky D; Goldman JM
    Int J Cell Cloning; 1984 Jul; 2(4):227-42. PubMed ID: 6086776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of proliferating potential of myeloid leukemia cells during long-term treatment with vitamin D3 analogues and other differentiation inducers in combination with antileukemic drugs: in vitro and in vivo studies.
    Kasukabe T; Honma Y; Hozumi M; Suda T; Nishii Y
    Cancer Res; 1987 Jan; 47(2):567-72. PubMed ID: 3466692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation therapy.
    Paquette RL; Koeffler HP
    Hematol Oncol Clin North Am; 1992 Jun; 6(3):687-706. PubMed ID: 1377195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological activities of 26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin D3 on human promyelocytic leukemic HL-60 cells: effects of fetal bovine serum and of incubation time.
    Okuno S; Inaba M; Nishizawa Y; Morii H
    Miner Electrolyte Metab; 1995; 21(1-3):211-6. PubMed ID: 7565452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of 1,25-dihydroxyvitamin D3 and its 20-epi analogues (MC 1288, MC 1301, KH 1060), on clonal keratinocyte growth: evidence for differentiation of keratinocyte stem cells and analysis of the modulatory effects of cytokines.
    Gniadecki R
    Br J Pharmacol; 1997 Mar; 120(6):1119-27. PubMed ID: 9134225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 25-Hydroxyvitamin D3, the prohormone of 1,25-dihydroxyvitamin D3, inhibits the proliferation of primary prostatic epithelial cells.
    Barreto AM; Schwartz GG; Woodruff R; Cramer SD
    Cancer Epidemiol Biomarkers Prev; 2000 Mar; 9(3):265-70. PubMed ID: 10750664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 19-nor-26,27-bishomo-vitamin D3 analogs: a unique class of potent inhibitors of proliferation of prostate, breast, and hematopoietic cancer cells.
    Kubota T; Koshizuka K; Koike M; Uskokovic M; Miyoshi I; Koeffler HP
    Cancer Res; 1998 Aug; 58(15):3370-5. PubMed ID: 9699668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.